Table 5 Related examination indicators after treatment
Indexes | Control (n = 98) | HP (n = 67) | CVVH (n = 59) | SHP (n = 135) | SHP + CVVH (n = 128) | P |
|---|---|---|---|---|---|---|
Maximum BUN (mmol/L) | 49.96 ± 22.8 | 37.03 ± 18.3a | 45.04 ± 23.90 | 27.13 ± 14.58abc | 13.44 ± 12.05abcd | <0.001 |
Maximum CREA (μmol/L) | 749.01 ± 291.02 | 411.22 ± 174.40a | 504.77 ± 183.30a | 241.11 ± 108.23abc | 174.26 ± 91.74bcd | <0.001 |
Maximum AST (IU/L) | 88.71 ± 76.63 | 90.04 ± 70.35 | 92.05 ± 70.88 | 84.08 ± 75.54a | 87.03 ± 65.45abcd | 0.018 |
Maximum ALT (IU/L) | 104.43 ± 62.20 | 101.99 ± 63.47 | 103.24 ± 66.41 | 95.07 ± 73.30 | 91.47 ± 71.12 | <0.001 |
Arterial blood gas analysis | ||||||
Minimum PH (mmHg) | 7.24 ± 0.11 | 7.21 ± 0.16 | 7.26 ± 0.13b | 7.29 ± 0.10b | 7.28 ± 0.13 | <0.001 |
Minimum PO2 (mmHg) | 34.17 ± 24.07 | 52.22 ± 26.79a | 41.03 ± 17.79b | 63.71 ± 28.84 ac | 72.20 ± 13.49abcd | <0.001 |
Maximum PCO2 (mmHg) | 46.43 ± 14.05 | 47.02 ± 13.99 | 47.10 ± 13.01 | 45.07 ± 12.14abc | 46.82 ± 11.94abc | <0.001 |